The antinociceptive effects of fluoxetine

Pain Clinic

Volumn 9, Issue 3, 1996, Pages 349-356

  Schreiber, Shaul ^a   Backer, Maria M ^b   Weizman, Ronit ^b   Pick, Chaim G ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

5 HT receptors; Analgesia; Antidepressants; Antinociceptive effect; Hotplate assay; Opioid receptors; Pain; Serotonin selective reuptake inhibitors

Indexed keywords

FLUOXETINE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN UPTAKE INHIBITOR; SIGMA OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030453456     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tura B, Tura SM. The analgesic effect of tricyclic antidepressants. Brain Res 1990; 518: 19-22.
2. Spiegel K, Kalb R, Pasternak GW. Analgesic activity of tricyclic antidepressant. Ann Neurol 1983; 13: 462-5.
3. Taub A, Collins WF. Observations on the treatment of denervation dysesthesia with psychotropic drugs: postherpetic neuralgia, anesthesia dolorosa, peripheral neuropathy. In: Bonica JJ, ed. Advances in Neurology. New York: Raven Press, 1974: 309.
4. Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Neurology 1976; 4: 457.
5. Diamond S, Baltes BJ. Chronic tension headache treated with amitriptyline: a double blind study. Headache 1971; 11: 110.
6. Foley KM. Pain syndromes in patients with cancer. In: Bonica JJ, Ventafridda V, eds. Advances in Pain Research and Therapy, Vol. 2. New York: Raven Press, 1979: 59.
7. Woodeford JM, Dwyer B, McEwen BW. Treatment of postherpetic neuralgia. Med J Aust 1965; 2: 869.
8. Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by direct action on the central nervous system. Ann Neurol 1983; 13: 160.
9. Pick CP, Paul D, Eison MS, Pasternak GW. Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 1992; 211: 375-81.
10. Schreiber S, Backer MM, Pick CG. The opioid properties of a tetracyclic antidepressant. Analgesia 1995; 1: 707-10.
11. Leonard BE. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 1992; 43 (Suppl. 2): 3-10.
12. Max MB. Antidepressants as analgesics. Prog Pain Res Manage 1994; 1: 229-46.
13. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992; 52: 547-52.
14. Hynes MD, Lochner MA, Bemis KG, Hymson DL. Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors. Life Sci 1985; 36: 2317-23.
15. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol Chemother 1957; 12: 12-5.
16. Hylden JLK, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313-6.
17. Woolfe G, MacDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther 1944; 80: 300-7.
18. Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl and Dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385-93.
19. Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and β-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 1987; 26: 153-8.
20. Banks WA, Kastin AJ, Trentman TL, Haynes HS, Johnson BG, Galina ZH. Mediation of serotonin-induced analgesia by the 5-HT receptor in the pentobarbital anaesthetized mouse model. Brain Res Bull 1988; 21: 887-91.